MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes-Reference-Cited by-同舟云学术

MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes

Published:2012-04 Issue:1-3 Volume:681 Page:80-87
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Sellers Zachary M.,Naren Anjaparavanda P.,Xiang Yang,Best Philip M.

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Targeted disruption of β2-adrenergic gene;Chruscinski;J. Biol. Chem.,1999

2. Equilibrium between adenylyl cyclase and phosphodiesterase patterns adrenergic agonist dose-dependent spatiotemporal cAMP/PKA activities in cardiomyocytes;De Arcangelis;Mol. Pharmacol.,2010

3. Phospholemman–phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes;Despa;Circ. Res.,2005

4. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice;Devic;Mol. Pharmacol.,2001

5. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments;DiPilato;Proc. Natl. Acad. Sci. U.S.A.,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Modulation of the Ca2+/cAMP/Adenosine Signaling in Cardiac Cells as a New Cardioprotective Strategy to Reduce Severe Arrhythmias in Myocardial Infarction;Pharmaceuticals;2023-10-16

2. TIMP3 induces gene expression partly through PI3K and their association with vascularization and heart rate;Frontiers in Cardiovascular Medicine;2023-03-28

3. Pharmacological Modulation by Low Molecular Weight Heparin of Purinergic Signaling in Cardiac Cells Prevents Arrhythmia and Lethality Induced by Myocardial Infarction;Journal of Cardiovascular Development and Disease;2023-02-27

4. Role of cardiac β1-adrenergic and A1-adenosine receptors in severe arrhythmias related to Parkinson's disease;Clinics;2023-01

5. Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia;Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine;2022-12-15